Psoriasis Paid Clinical Trial (21-502)

Psoriasis

21-502, £3,250 (in partial payments) + reasonable travel expenses

People with mild to moderate plaque-type psoriasis needed for the study of a potential new medicine to treat the condition. You must be aged 18 to 65 years old and have a confirmed diagnosis for at least 6 months. Smokers of up to 20 cigarettes or equivalent per day allowed. It involves 1 session of 4 nights’ residence and 9 outpatient visits, over 3 months. Study ongoing and groups starting regularly.